Correlation Between Day One and Orgenesis

Can any of the company-specific risk be diversified away by investing in both Day One and Orgenesis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Orgenesis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Day One Biopharmaceuticals and Orgenesis, you can compare the effects of market volatilities on Day One and Orgenesis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Orgenesis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Orgenesis.

Diversification Opportunities for Day One and Orgenesis

0.25

Correlation Coefficient

Day One  Orgenesis

Modest diversification

The 3 months correlation between Day and Orgenesis is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Orgenesis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orgenesis and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Orgenesis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orgenesis has no effect on the direction of Day One i.e., Day One and Orgenesis go up and down completely randomly.

Pair Corralation between Day One and Orgenesis

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Orgenesis. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 2.22 times less risky than Orgenesis. The stock trades about -0.05 of its potential returns per unit of risk. The Orgenesis is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  82.00  in Orgenesis on March 28, 2024 and sell it today you would lose (23.00) from holding Orgenesis or give up 28.05% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.39%
Values	Daily Returns

Day One Biopharmaceuticals  vs.  Orgenesis

Day One Biopharmaceu

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in July 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Orgenesis

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Orgenesis has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Orgenesis is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Day One and Orgenesis

The main advantage of trading using opposite Day One and Orgenesis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Orgenesis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orgenesis will offset losses from the drop in Orgenesis' long position.

The idea behind Day One Biopharmaceuticals and Orgenesis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.